Navigation Links
Major aspergillus genomics supplement published by journal Fungal Genetics and Biology
Date:4/2/2009

Amsterdam, 2 April 2009 A major effort from within the Aspergillus community has resulted in the publication of an exceptional supplement by the Elsevier journal Fungal Genetics and Biology (www.elsevier.com/locate/yfgbi). The supplement provides extensive studies based on the genome analysis of two Aspergillus species: Aspergillus niger and Aspergillus nidulans. The publication was enabled by Eurofungbase, a coordination action programme funded by the European Commission, and was strongly supported by DSM.

Aspergillus species are widely exploited by the fermentation industry for the production of foodstuffs, enzymes and organic acids. Others have been object of study for many years because of their use in the development of medications to treat human and animal infections.

Prof. Neil Gow, Editor-in-Chief of Fungal Genetics and Biology, commented: "The vast amount of data that is captured in the Aspergillus supplement will support fungal biologists around the globe and help to inform those whose work is dedicated to fighting fungal infections."

The large scale A. nidulans and A. niger annotation projects that are the basis of the publication, base their success on combining the strengths of different expert groups. Dr. Jaap Visser, one of the Guest Editors and main driver behind the project, noted: "Besides mobilizing the Aspergillus community, this meant preparing and developing an outstanding infrastructure that would enable such a large annotation effort to be effective."

The publication aims to stimulate research on A. nidulans and A. niger in order to increase knowledge of these organisms and their application on key issues of today's world: health, environment and food. The supplement provides an invaluable resource not just for scientists studying Aspergillus, but for a large community of fungal biologists and medical researchers worldwide.


'/>"/>

Contact: Alina Helsloot
a.helsloot@elsevier.com
31-204-853-835
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Source of major health benefits in olive oil revealed
2. A missing enzyme conveys major heart protection in pre-clinical work
3. Major NSF grant boosts UNH research on hormonal genomics
4. Rising sea levels set to have major impacts around the world
5. Cellulosic biofuel technology will generate low-cost green fuel, says major study
6. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
7. NJIT to host major biomedical engineering showcase and career fair
8. Major step for drug discovery and diagnostics
9. Forsyth scientist receives major grant to support rapid, accurate, affordable test for tuberculosis
10. Foretelling a major meltdown
11. Major conference on food Dec. 1-2, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... ... Research and Markets has announced the addition of the "Global ... The report forecasts the global military biometrics market to grow at a ... has been prepared based on an in-depth market analysis with inputs from ... over the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners has ... pioneering medical device for the treatment of Age-Related Macular Degeneration. , The company’s ... global regulatory consultancy that helps companies like ours secure government approvals for their ...
(Date:1/21/2017)... Colo. , Jan. 20, 2017 ... or the "Company"), announced that on January 14, 2017 ... plan under which the Company will terminate certain employees ... Bioptix Diagnostics, Inc.  The Company commenced terminations on January ... within 30 days.  The Company may pay severance benefits ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, today presented data ... napabucasin, at the 2017 American Society of Clinical Oncology ... . In a Phase Ib/II ... designed to inhibit cancer stemness pathways by targeting STAT3 ...
(Date:1/20/2017)... 20, 2017 Stock-Callers.com explores the ... influenced the most recent performances of select equities. In ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... ), and Sage Therapeutics Inc. (NASDAQ: SAGE ... View Research, global Biotech market size is expected to reach $604.40 billion by ...
Breaking Biology Technology: